Patients with multiple myeloma are at increased risk for infection due to functional hypogammaglobulinemia and therapy related immunosuppression and are vulnerable to severe COVID-19 infections. We evaluated antibody response to currently available vaccines against SARS-CoV-2 in patients with plasma cell...
The on-going COVID-19 pandemic triggered the implementation of new vaccine platforms. The global use of COVID-19 vaccine verification most probably will influence practices and perceptions of vaccination policies for travelers the coming years. Read full articleView PDF Legal Issues in Public Health...
The global COVID-19 pandemic has brought the subject of vaccine confidence to the forefront, along with new interest and debate about vaccination relating to individual choice vs population health. The impact of vaccination as a milestone achievement in public health is irrefutable; nonetheles...
New Jersey is providing the COVID-19 vaccine developed by Pfizer, Inc. to hospital systems for vaccinations of health care workers, and to a number of regional and national chain pharmacies for distribution to long term-care facility residents. Staff at RWJ-Somerset began receiving shots the wee...
The purposes of our study are to map high-risk areas in Canada as well as quantifying the effects of vaccination intervention and socio-demographic factors on the transmission rates of infection, recovery, and death related to COVID-19. The data of this research included weekly number of COVID...
Johnson & Johnson COVID-19 Vaccine Candidate Interim Phase 1/2a Data Published inNew England Journal of Medicine. [news release]. New Brunswick, NJ; January 13, 2021: Johnson & Johnson. Accessed January 15, 2021.https://www.jnj.com/johnson-johnson-covid-19-vaccine-candidate-interim...
Max Eburne, JCDecaux’s Chief Commercial Officer, said.“JCDecaux has sought to help businesses, our frontline workers and the Government during the COVID-19 pandemic. We have been part of the regional ’Shop Local’ campaign in partnership with SCA and featured our own ‘Thank you’ campaign...
COVID-19 were granted emergency use authorization (EUA) by the Food and Drug Administration, two RNA platform technology (mRNA-1273, Moderna (Cambridge, MA); and BNT162b2, Pfizer, New York, NY) and one adenovirus vector vaccine (Ad.26.COV2.S, Johnson and Johnson, New Brunswick, NJ) [...
Among the vaccinated patients, 1 received the Janssen (Ad.26.COV2.S) COVID-19 vaccine (Janssen Biotech, Inc, Pharmaceutical Companies of Johnson & Johnson, New Brunswick, NJ), 12 received the Moderna vaccine, and 127 received the Pfizer-BioNTech vaccine (Supplemental Table 1 provided in the...
Neuroticism predicts national vaccination rates across 56 countriesCurrent Psychology - Quite strikingly, there is significant variation in Covid-19 vaccine coverage around the world. Some countries do not progress from around 2-3% while others are close to 100%......